IPHA
USDInnate Pharma S.A. ADS
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$1.880
Haut
$1.880
Bas
$1.840
Volume
0.00M
Fondamentaux de l'Entreprise
Capitalisation Boursière
172.7M
Industrie
Biotechnologie
Pays
France
Statistiques de Trading
Volume Moyen
0.02M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
Regulatory News: Innate Pharma SA (PARIS:IPH, NASDAQ:IPHA) ("Innate" or the "Company") today announced that the Company will hold a conference call on Thursday, November 13, 2025, at 2 p.m. CET / 8 a.m. ET, to give an
HC Wainwright & Co. Upgrades Innate Pharma to Buy, Announces $5 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Innate Pharma from Neutral to Buy and announces $5 price target.
BTIG Reiterates Buy on Innate Pharma, Maintains $8 Price Target
BTIG analyst Justin Zelin reiterates Innate Pharma with a Buy and maintains $8 price target.
Actions Connexes
JSPRW
Japer Therapeutics Inc. Warrants
NRSNW
NeuroSense Therapeutics Ltd. Warrant
INBS
Intelligent Bio Solutions Inc.
KDLYW
Kindly MD Inc. Warrants
ENLV
Enlivex Therapeutics Ltd. Ordinary Shares
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.